Julie Torode is a board member of the Institute of Cancer Policy, Director of Strategic Partnerships, Community and Patient Engagement and visiting researcher at Kings College London. Her research interests span the spectrum of global cancer prevention and control with a particular interest in women’s health and cancer. Julie gained her PhD in Chemistry from the University of Liverpool, conducted post-doctoral research at the University of Marburg, Germany and entered the health arena and field of oncology through industry clinical trials work across phases I-IV (2000-2008). Since then, Julie has worked internationally with a policy focus and global advocacy working alongside United Nations agencies and government bodies. During more than a decade (2008-2021) at Union for International Cancer Control in Geneva, Switzerland Julie worked with cancer organisations across the globe in advocating for the Global Action Plan on Noncommunicable Diseases, the palliative care and cancer resolutions and most recently the WHO Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Her global cancer research covers cancer systems strengthening: access to cancer medicines and palliative care, global radiotherapy and cancer care in conflict. She is currently co-chair of the WHO Global Guideline Group for Cervical Cancer, serving on a WHO working group in the Global Breast Cancer Initiative and supports several civil society organisations in Sub-Saharan Africa as a board member or advisor.